Accutest Biologics Private Limited, a active private limited company, was established on 03 August 2012 in Navi Mumbai, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U74900MH2012PTC234115. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 M.
Formerly known as Quantimmune Solutions Private Limited. It upholds a compliant status. Its leadership includes Uma Ramachandran (Additional Director), Ashvin Joseph George (Nominee Director), Devireddy Reddy Madhusudhana (Additional Director). Past directors included Mallikarjun Narayan Dixit, Satish Vithhal Sawant, Suneel Regulla. It holds ₹60.00 Cr open charges and ₹131.86 Cr settled loans. Its latest AGM occurred on 19 December 2024, with the balance sheet filed on 31 March 2024. It is based at A-77, Midc, Ttc Industrial Area, Khairane Navi Mumbai, Navi Mumbai, Maharashtra, 400709.
U74900MH2012PTC234115
234115
03 August 2012
₹2.00 Cr
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Accutest Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uma Ramachandran | Additional Director | 07 Jun 2025 | Current |
| Ashvin Joseph George | Nominee Director | 07 Oct 2022 | Current |
| Devireddy Reddy Madhusudhana | Additional Director | 07 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Mar 2020 | Past |
| Pramod Abcsdd | Director | 11 Dec 2023 | Past |
| Pramod Abcsdd | Nominee Director | 06 Jul 2025 | Past |
| Pramod Abcsdd | Director | 07 Oct 2022 | Past |
| Pramod Abcsdd | Director | 26 Jun 2013 | Past |
| Pramod Abcsdd | Director | 14 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Accutest Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 91.26% decrease. The company also saw a substantial improvement in profitability, with a 372.12% increase in profit. The company's net worth Soared by an impressive increase of 32.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Accutest Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹600,000,000.00
₹1,318,576,961.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2025 | Others | ₹30.00 Cr | Open |
| 03 Oct 2022 | Tata Capital Financial Services Limited | ₹30.00 Cr | Open |
| 05 Nov 2018 | Others | ₹112.04 Cr | Satisfied |
| 09 Jul 2014 | The Shamrao Vithal Co-Operative Bank Limited | ₹1.15 Cr | Satisfied |
| 07 Feb 2013 | The Shamrao Vithal Co-Operative Bank Limited | ₹18.67 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Accutest Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Accutest Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accutest Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Anjali Bharatkumar Sampat was appointed as a Company Secretary was appointed as a Company Secretary on 06 Nov 2025 & has been associated with this company since 1 month 14 days . was recorded as a recent event.
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101177859 was registered on 20 Oct 2025. was recorded as a recent event.
Uma Ramachandran was appointed as a Additional Director was appointed as a Additional Director on 07 Jun 2025 & has been associated with this company since 6 months 16 days . was recorded as a recent event.
Progress on Devireddy Reddy Madhusudhana was appointed as a Additional Director was appointed as a Additional Director on 07 Jun 2025 & has been associated with this company since 6 months 16 days . was documented.
The activity Accutest Biologics Private Limited last Annual general meeting of members was held on 19 Dec 2024 as per latest MCA records. was completed.
Progress on Accutest Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Bengaluru , Aug 19, 2019: India’s clinical contract research industry, with current market size of USD 500mn is poised to double over five years and achieve Billion dollar market club. As a leading In.
/PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services....
The CIN of Accutest Biologics Private Limited is U74900MH2012PTC234115.
Accutest Biologics Private Limited is headquartered at A-77, Midc, Ttc Industrial Area, Khairane Navi Mumbai, Navi Mumbai, Maharashtra, 400709.
Accutest Biologics Private Limited was incorporated on 03 August 2012.
The current directors of Accutest Biologics Private Limited are
The primary industry of Accutest Biologics Private Limited is Professional, Scientific And Technical.
Accutest Biologics Private Limited is unlisted.
The authorized capital of Accutest Biologics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 M.
The compliance status of Accutest Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX